BCM

Boxer Capital Management Portfolio holdings

AUM $199M
This Quarter Est. Return
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$332M
AUM Growth
-$842M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
62
New
Increased
Reduced
Closed

Top Buys

1 +$4.59M
2 +$3.4M
3 +$308K
4
KOD icon
Kodiak Sciences
KOD
+$98.3K

Top Sells

1 +$124M
2 +$105M
3 +$50.5M
4
NUVL icon
Nuvalent
NUVL
+$47.5M
5
AXSM icon
Axsome Therapeutics
AXSM
+$39.8M

Sector Composition

1 Healthcare 99.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CLYM
26
Climb Bio
CLYM
$131M
$177K 0.05%
145,000
-2,458,190
NUVB.WS icon
27
Nuvation Bio Inc Warrants
NUVB.WS
$64.4M
$85.3K 0.03%
266,666
SRZNW icon
28
Surrozen Inc Warrant
SRZNW
$36K
$2K ﹤0.01%
66,666
MRSN icon
29
Mersana Therapeutics
MRSN
$49.3M
-105,400
OBIO icon
30
Orchestra BioMed
OBIO
$179M
-238,193
OLMA icon
31
Olema Pharmaceuticals
OLMA
$642M
-650,000
RCKT icon
32
Rocket Pharmaceuticals
RCKT
$400M
-1,466,051
RCUS icon
33
Arcus Biosciences
RCUS
$1.75B
-1,602,200
RLAY icon
34
Relay Therapeutics
RLAY
$1.12B
-536,132
SANA icon
35
Sana Biotechnology
SANA
$1.29B
-1,545,000
SMMT icon
36
Summit Therapeutics
SMMT
$15.6B
-250,000
SRRK icon
37
Scholar Rock
SRRK
$2.69B
-750,000
SWTX
38
DELISTED
SpringWorks Therapeutics
SWTX
-3,421,541
SYRE icon
39
Spyre Therapeutics
SYRE
$1.74B
-466,680
TERN icon
40
Terns Pharmaceuticals
TERN
$736M
-752,000
THRD
41
DELISTED
Third Harmonic Bio
THRD
-2,000,000
TYRA icon
42
Tyra Biosciences
TYRA
$773M
-2,027,678
ZNTL icon
43
Zentalis Pharmaceuticals
ZNTL
$107M
-450,000
ZURA icon
44
Zura Bio
ZURA
$209M
-300,000
BCAX
45
Bicara Therapeutics
BCAX
$997M
-135,000
PSTX
46
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
-2,000,000
APGE icon
47
Apogee Therapeutics
APGE
$3.73B
-86,000
ARVN icon
48
Arvinas
ARVN
$699M
-1,058,614
AXSM icon
49
Axsome Therapeutics
AXSM
$6.38B
-470,000
BCAB icon
50
BioAtla
BCAB
$48.7M
-686,347